Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technology evaluation: Kahalalide F, PharmaMar.

Mark T Hamann1

  • 1University of Mississippi, The School of Pharmacy and Department of Chemistry and Biochemistry, PO Box 1848, MS 38677, USA. mthamann@olemiss.edu

Current Opinion in Molecular Therapeutics
|January 25, 2005
PubMed
Summary

Kahalalide F, a novel depsipeptide, shows promise for treating solid tumors. PharmaMar is advancing this potential cancer therapy through phase II clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metformin-like Methylglyoxal Scavengers from Macroalgae <i>Chondrus crispus</i> and <i>Gracilaria vermiculophyla</i> Preserve Cell Viability.

Marine drugs·2026
Same author

Fragment-Based Online OzESI-MS, NMR, and Computational DP4+/DFT Approaches to the Characterization of the Putative Biosynthetic Lipid Precursor of Atkamine from Alaskan <i>Latrunculia</i> Sponges.

ACS omega·2026
Same author

On the Discorhabdins Leading to the Aleutianamine Ring System: A One-Step in Situ Transformation Characterized Through Computational and Experimental Studies and Its Implications on Biosynthesis, Synthesis, and Pharmacology.

Angewandte Chemie (International ed. in English)·2026
Same author

Aleutianamine B, A Novel Chiral Sulfoxide Isolated from <i>Latrunculia</i> spp. and Generated via Semi-Synthesis, Exhibits Selectivity for Ovarian Cancer Cells.

Journal of natural products·2025
Same author

Methylglyoxal mutagenizes single-stranded DNA via Rev1-associated slippage and mispairing.

Nucleic acids research·2025
Same author

Bletistrosides M-X, Anti-Alzheimer's Disease Compounds from the Tubers of <i>Bletilla striata</i>.

Journal of natural products·2025

Area of Science:

  • Oncology
  • Pharmacology
  • Marine Biotechnology

Background:

  • Solid tumors represent a significant global health challenge.
  • Novel therapeutic agents are continuously needed to improve cancer treatment outcomes.
  • Depsipeptides are a class of compounds with diverse biological activities.

Purpose of the Study:

  • To evaluate the efficacy and safety of Kahalalide F as a treatment for solid tumors.
  • To advance the clinical development of Kahalalide F.

Main Methods:

  • Kahalalide F is a depsipeptide derived from a marine organism.
  • The compound is currently being investigated in phase II clinical trials.
  • Clinical trial design involves assessing patient response and adverse events.

Main Results:

  • Preliminary data on Kahalalide F's efficacy and safety are being collected.
  • Phase II trials are designed to determine the optimal dosage and identify potential benefits.
  • Further results are pending the completion of ongoing trials.

Conclusions:

  • Kahalalide F is a potential new therapeutic option for patients with solid tumors.
  • Ongoing clinical trials will provide critical data on its clinical utility.
  • The development of Kahalalide F highlights the potential of marine-derived compounds in cancer therapy.

Related Experiment Videos